Sunday, December 21, 2025 | 09:38 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Shilpa Medicare receives Import Alert for its Telangana facility

Image

Capital Market

Three products exempted from Import Alert

Shilpa Medicare has received an Import Alert 66-40 on 17 February 2021, pursuant to the USFDA inspection of the Unit 4, Jadcherla, Telangana facility from 13 February to 20 February and 24 February to 25 February 2020.

The company announced that three products have been exempted from the Import Alert - Azacitidine for Injection, Cyclophosphamide Capsules and Erlotinib Tablets

Powered by Capital Market - Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 18 2021 | 2:44 PM IST

Explore News